Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

Related Articles by Review for PubMed (Select 17235331)

1.

Risk of extrapyramidal syndrome in schizophrenic patients treated with antipsychotics: a population-based study.

Yang SY, Kao Yang YH, Chong MY, Yang YH, Chang WH, Lai CS.

Clin Pharmacol Ther. 2007 Apr;81(4):586-94. Epub 2007 Jan 18.

PMID:
17235331
2.

EPS profiles: the atypical antipsychotics are not all the same.

Weiden PJ.

J Psychiatr Pract. 2007 Jan;13(1):13-24. Review.

PMID:
17242588
3.

Effects of newer antipsychotics on extrapyramidal function.

Tarsy D, Baldessarini RJ, Tarazi FI.

CNS Drugs. 2002;16(1):23-45. Review. Erratum in: CNS Drugs. 2003;17(3):202.

PMID:
11772117
4.

Extrapyramidal adverse events associated with atypical antipsychotic treatment of bipolar disorder.

Gentile S.

J Clin Psychopharmacol. 2007 Feb;27(1):35-45. Review.

PMID:
17224710
5.
6.
7.

Tardive dyskinesia and new antipsychotics.

Correll CU, Schenk EM.

Curr Opin Psychiatry. 2008 Mar;21(2):151-6. doi: 10.1097/YCO.0b013e3282f53132. Review.

PMID:
18332662
8.

Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons.

Haddad PM, Das A, Keyhani S, Chaudhry IB.

J Psychopharmacol. 2012 May;26(5 Suppl):15-26. doi: 10.1177/0269881111424929. Epub 2011 Nov 5. Review.

PMID:
22057019
9.

Use and safety of antipsychotic drugs during pregnancy.

Einarson A, Boskovic R.

J Psychiatr Pract. 2009 May;15(3):183-92. doi: 10.1097/01.pra.0000351878.45260.94. Review.

PMID:
19461391
10.
11.

The Mount Sinai conference on the pharmacotherapy of schizophrenia.

Marder SR, Essock SM, Miller AL, Buchanan RW, Davis JM, Kane JM, Lieberman J, Schooler NR.

Schizophr Bull. 2002;28(1):5-16. Review.

12.

Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making.

Volavka J, Citrome L.

Expert Opin Pharmacother. 2009 Aug;10(12):1917-28. doi: 10.1517/14656560903061309. Review.

PMID:
19558339
13.

Akathisia: an updated review focusing on second-generation antipsychotics.

Kane JM, Fleischhacker WW, Hansen L, Perlis R, Pikalov A 3rd, Assunção-Talbott S.

J Clin Psychiatry. 2009 Apr 21;70(5):627-43. doi: 10.4088/JCP.08r04210. Review.

PMID:
19389331
14.

Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations.

Wobrock T, Soyka M.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1375-85. doi: 10.1016/j.pnpbp.2008.02.008. Epub 2008 Feb 26. Review.

PMID:
18394768
15.

Focus on lower risk of tardive dyskinesia with atypical antipsychotics.

Nasrallah HA.

Ann Clin Psychiatry. 2006 Jan-Mar;18(1):57-62. Review.

PMID:
16517454
16.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
17.

Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?

Tarsy D, Baldessarini RJ.

Mov Disord. 2006 May;21(5):589-98. Review.

PMID:
16532448
18.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
19.

[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].

Khaldi S, Kornreich C, Choubani Z, Gourevitch R.

Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2. Review. French.

PMID:
19081460
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk